ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients
Lung Cancer
◽
10.1016/j.lungcan.2007.12.002
◽
2008
◽
Vol 61
(1)
◽
pp. 67-72
◽
Cited By ~ 9
Author(s):
Cesare Gridelli
◽
Ermelinda De Maio
◽
Santi Barbera
◽
Mirella Sannicolò
◽
Elena Piazza
◽
...
Keyword(s):
Lung Cancer
◽
Elderly Patients
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Single Agent
◽
Small Cell
◽
Constant Infusion
◽
Phase 2
◽
Small Cell Lung
◽
Phase 2 Study
Download Full-text
Related Documents
Cited By
References
Abstract P048: A phase 2 study of VS-6766 (dual RAF/MEK inhibitor) RAMP 202, as a single agent and in combination with defactinib (FAK inhibitor) in recurrent KRAS-mutant (KRAS-MT) non-small cell lung cancer (NSCLC)
10.1158/1535-7163.targ-21-p048
◽
2021
◽
Author(s):
D. Ross Camidge
◽
Jonathan Pachter
◽
Andrew Koustenis
◽
Gloria Patrick
◽
David R. Spigel
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Single Agent
◽
Mek Inhibitor
◽
Small Cell
◽
Phase 2
◽
Small Cell Lung
◽
Phase 2 Study
Download Full-text
Faculty Opinions recommendation of Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717969276.793473915
◽
2013
◽
Cited By ~ 1
Author(s):
Sam Janes
◽
Laura Succony
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase 2
◽
Small Cell Lung
◽
Phase 2 Study
Download Full-text
Faculty Opinions recommendation of Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717969276.793468807
◽
2013
◽
Author(s):
Thomas Stinchcombe
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase 2
◽
Small Cell Lung
◽
Phase 2 Study
Download Full-text
P82.02 Stereotactic Ablative Radiotherapy with Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer: a phase 2 study
Journal of Thoracic Oncology
◽
10.1016/j.jtho.2021.01.1193
◽
2021
◽
Vol 16
(3)
◽
pp. S651-S652
Author(s):
J. Beal
◽
D. Gomes
◽
P. Taranto
◽
L. Koch
◽
A.C. Rezende
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Early Stage
◽
Small Cell
◽
Stereotactic Ablative Radiotherapy
◽
Phase 2
◽
Small Cell Lung
◽
Phase 2 Study
Download Full-text
Anlotinib vs placebo as third- or further-line treatment for patients with small cell lung cancer: a randomised, double-blind, placebo-controlled Phase 2 study
British Journal of Cancer
◽
10.1038/s41416-021-01356-3
◽
2021
◽
Author(s):
Ying Cheng
◽
Qiming Wang
◽
Kai Li
◽
Jianhua Shi
◽
Ying Liu
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Line Treatment
◽
Phase 2
◽
Small Cell Lung
◽
Double Blind
◽
Double Blind Placebo
◽
Phase 2 Study
Download Full-text
P2.01-19 Phase 2 Study of Telisotuzumab Vedotin (Teliso-V) in Previously Treated c-MET+ Non-Small Cell Lung Cancer: Trial in Progress
Journal of Thoracic Oncology
◽
10.1016/j.jtho.2019.08.1363
◽
2019
◽
Vol 14
(10)
◽
pp. S646
◽
Cited By ~ 1
Author(s):
C. Ocampo
◽
J. Wu
◽
J. Dey
◽
Z. Sun
◽
M. Motwani
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase 2
◽
Small Cell Lung
◽
Cancer Trial
◽
Phase 2 Study
◽
Previously Treated
Download Full-text
Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer
Lung Cancer
◽
10.1016/j.lungcan.2011.09.006
◽
2012
◽
Vol 76
(1)
◽
pp. 78-83
◽
Cited By ~ 22
Author(s):
Benjamin Besse
◽
David Planchard
◽
Anne-Sophie Veillard
◽
Laurent Taillade
◽
David Khayat
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase 2
◽
Small Cell Lung
◽
Phase 2 Study
Download Full-text
A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)
International Journal of Radiation Oncology*Biology*Physics
◽
10.1016/j.ijrobp.2015.07.2260
◽
2015
◽
Vol 93
(4)
◽
pp. 757-764
◽
Cited By ~ 155
Author(s):
Gregory M.M. Videtic
◽
Chen Hu
◽
Anurag K. Singh
◽
Joe Y. Chang
◽
William Parker
◽
...
Keyword(s):
Lung Cancer
◽
Radiation Therapy
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Stereotactic Body Radiation Therapy
◽
Small Cell
◽
Phase 2
◽
Small Cell Lung
◽
Phase 2 Study
◽
Randomized Phase 2
Download Full-text
Final Results of a Randomized Phase 2 Study Comparing Carboplatin Plus Irinotecan (Ci) Versus Carboplatin Plus Amrubicin (Ca) for Extensive Disease Small-Cell Lung Cancer: Njlcg0901
Annals of Oncology
◽
10.1093/annonc/mdu355.14
◽
2014
◽
Vol 25
◽
pp. iv515
Author(s):
Y. Tsukita
◽
N. Morikawa
◽
S. Sugawara
◽
M. Maemondo
◽
T. Harada
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase 2
◽
Small Cell Lung
◽
Extensive Disease
◽
Phase 2 Study
◽
Randomized Phase 2
Download Full-text
Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol
Clinical Lung Cancer
◽
10.1016/j.cllc.2018.10.008
◽
2019
◽
Vol 20
(2)
◽
pp. 134-138
◽
Cited By ~ 8
Author(s):
Takashi Ninomiya
◽
Nobuhisa Ishikawa
◽
Koji Inoue
◽
Toshio Kubo
◽
Masayuki Yasugi
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Study Protocol
◽
Cell Lung Cancer
◽
Small Cell
◽
Egfr Mutations
◽
Phase 2
◽
Small Cell Lung
◽
Phase 2 Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close